Carmolex careers

To date, most drug discovery efforts are failing because they are only able to sample a tiny portion of chemical space (protein targets); usually 1-5 million substances per project (molecules) are considered when trying to find a starting point. Carmolex’s exclusive software, enormous virtual small molecule libraries and world-class mastery of special chemistry empower it to be the most innovative engine for drug precursor discovery commercially available. Our AnchorQueryTM license and extensive InstantChemistryTM database make possible the design and virtual screening of today’s much more challenging chemical space (thousands of new protein targets recently discovered await intervention). Carmolex’s rational process overcomes traditional, slow, robotic screening (HTP) and the unpredictability of multi-step chemical synthesis, with smarter solutions able to increase the likelihood of successfully delivering molecules by several orders of magnitude.